1. Home
  2. PYXS vs ISRL Comparison

PYXS vs ISRL Comparison

Compare PYXS & ISRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYXS
  • ISRL
  • Stock Information
  • Founded
  • PYXS 2018
  • ISRL 2021
  • Country
  • PYXS United States
  • ISRL United States
  • Employees
  • PYXS N/A
  • ISRL N/A
  • Industry
  • PYXS Biotechnology: Pharmaceutical Preparations
  • ISRL Blank Checks
  • Sector
  • PYXS Health Care
  • ISRL Finance
  • Exchange
  • PYXS Nasdaq
  • ISRL Nasdaq
  • Market Cap
  • PYXS 75.0M
  • ISRL 79.7M
  • IPO Year
  • PYXS 2021
  • ISRL 2023
  • Fundamental
  • Price
  • PYXS $1.10
  • ISRL $12.55
  • Analyst Decision
  • PYXS Strong Buy
  • ISRL
  • Analyst Count
  • PYXS 5
  • ISRL 0
  • Target Price
  • PYXS $9.00
  • ISRL N/A
  • AVG Volume (30 Days)
  • PYXS 387.8K
  • ISRL 3.5K
  • Earning Date
  • PYXS 08-13-2025
  • ISRL 01-01-0001
  • Dividend Yield
  • PYXS N/A
  • ISRL N/A
  • EPS Growth
  • PYXS N/A
  • ISRL N/A
  • EPS
  • PYXS N/A
  • ISRL 0.20
  • Revenue
  • PYXS N/A
  • ISRL N/A
  • Revenue This Year
  • PYXS N/A
  • ISRL N/A
  • Revenue Next Year
  • PYXS N/A
  • ISRL N/A
  • P/E Ratio
  • PYXS N/A
  • ISRL $62.36
  • Revenue Growth
  • PYXS N/A
  • ISRL N/A
  • 52 Week Low
  • PYXS $0.83
  • ISRL $11.08
  • 52 Week High
  • PYXS $5.39
  • ISRL $14.00
  • Technical
  • Relative Strength Index (RSI)
  • PYXS 43.52
  • ISRL 49.18
  • Support Level
  • PYXS $1.12
  • ISRL $12.41
  • Resistance Level
  • PYXS $1.38
  • ISRL $12.99
  • Average True Range (ATR)
  • PYXS 0.08
  • ISRL 0.14
  • MACD
  • PYXS -0.01
  • ISRL -0.01
  • Stochastic Oscillator
  • PYXS 5.08
  • ISRL 77.27

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

About ISRL Israel Acquisitions Corp

Israel Acquisitions Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: